Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A new proteogenomic approach combined with long-read sequencing and HLA-ligandome to identify novel neoantigens

ABSTRACT: Mass spectrometry data of human melanoma HLA peptidomes

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Takayuki Kanaseki

PROVIDER: PXD056367 | JPOST Repository | Fri Dec 26 00:00:00 GMT 2025

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	MEL02_HLA_II_1.raw	Raw
	MEL02_HLA_II_2.raw	Raw
	MEL02_HLA_II_3.raw	Raw
	MEL02_HLA_I_1.mgf	Mgf
	MEL02_HLA_I_1.raw	Raw

Items per page:

1 - 5 of 20

Similar Datasets

Estimating the Contribution of Proteasomal Spliced Peptides to the HLA-I Ligandome.

Project description: Not available

| S-EPMC6283289 | biostudies-literature

Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes.

Project description: Not available

| S-EPMC7064602 | biostudies-literature

The HLA Ligandome Comprises a Limited Repertoire of O-GlcNAcylated Antigens Preferentially Associated With HLA-B*07:02.

Project description: Not available

| S-EPMC8671986 | biostudies-literature

Mapping the HLA Ligandome of Colorectal Cancer Reveals an Imprint of Malignant Cell Transformation.

Project description: Not available

| S-EPMC6235106 | biostudies-literature

new HLA

Project description:Identification of a novel HLA allele

| PRJEB31637 | ENA

Mining small RNA sequencing data: a new approach to identify small nucleolar RNAs in Arabidopsis.

Project description: Not available

| S-EPMC2685112 | biostudies-literature

Pre-fractionation Extends but also Creates a Bias in the Detectable HLA Class Ι Ligandome.

Project description: Not available

| S-EPMC6456874 | biostudies-literature

A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues, fractionated approach

Project description:Malignant melanoma has currently the highest increase of incidence of malignancies in the western world. In early stages, front line therapy is surgical excision of the primary tumor. Metastatic disease has previously has very limited possibilities to be cured. Recently, several protein kinase inhibitors and immune modifiers have shown promising results but drug resistance in metastasized melanoma remains a major problem. The need for clinical biomarkers to follow disease progression and treatment effects is high. The aim of the present study was to build a protein sequence database in metastatic melanoma, searching for novel, relevant biomarkers. Ten lymph node metastases (South-Swedish Malignant Melanoma Biobank) were subjected to global protein expression analysis using two proteomics approaches (with/without orthogonal fractionation). Fractionation produced higher numbers of protein identifications (4284). Combining both methods, 5326 unique proteins were identified (2641 proteins overlapping). Deep mining proteomics may contribute to the discovery of novel biomarkers for metastatic melanoma, for example dividing the samples into two metastatic melanoma "genomic subtypes", ("pigmentation" and "high immune") revealed several proteins showing differential levels of expression. In conclusion, the present study provides an initial version of a metastatic melanoma protein sequence database producing a total of more than 5000 unique protein identifications. This dataset consists of data for four samples, analysed by applying strong cation exchange chromatography (SCX) step before the MS step. A sister dataset, consisting of ten samples (that included the current four), was analysed without the (SCX) step.

2015-04-17 | PXD001724 | Pride

A Protein Deep Sequencing Evaluation of Metastatic Melanoma Tissues, unfractionated approach

Project description:Malignant melanoma has currently the highest increase of incidence of malignancies in the western world. In early stages, front line therapy is surgical excision of the primary tumor. Metastatic disease has previously has very limited possibilities to be cured. Recently, several protein kinase inhibitors and immune modifiers have shown promising results but drug resistance in metastasized melanoma remains a major problem. The need for clinical biomarkers to follow disease progression and treatment effects is high. The aim of the present study was to build a protein sequence database in metastatic melanoma, searching for novel, relevant biomarkers. Ten lymph node metastases (South-Swedish Malignant Melanoma Biobank) were subjected to global protein expression analysis using two proteomics approaches (with/without orthogonal fractionation). Fractionation produced higher numbers of protein identifications (4284). Combining both methods, 5326 unique proteins were identified (2641 proteins overlapping). Deep mining proteomics may contribute to the discovery of novel biomarkers for metastatic melanoma, for example dividing the samples into two metastatic melanoma "genomic subtypes", ("pigmentation" and "high immune") revealed several proteins showing differential levels of expression. In conclusion, the present study provides an initial version of a metastatic melanoma protein sequence database producing a total of more than 5000 unique protein identifications. This dataset consists of data for ten samples. A sister dataset, consisting of four samples (that are included in the current ten), was analysed , analysed by applying strong cation exchange chromatography (SCX) step before the MS step.

2015-04-17 | PXD001725 | Pride

A new system identification approach to identify genetic variants in sequencing studies for a binary phenotype.

Project description: Not available

| S-EPMC4270367 | biostudies-literature